Streetbeat News

Stock Prices

SKIN

BeautyHealth announced a streamlining and transformation program aimed at generating cost savings. The company also announced a $100 million buyback authorization, which has led to an increase in its share price.

Portfolio Pulse from Bill Haddad

September 12, 2023 | 3:01 pm

THRY

Thryv Holdings (NASDAQ:THRY) has received positive analyst ratings in the last quarter, with 3 bullish and 1 somewhat bullish ratings. The average price target for the stock is $39.5, significantly higher than its current price of $18.83. This average target price has increased by 64.58% from the previous average of $24.00.

Portfolio Pulse from Benzinga Insights

September 12, 2023 | 3:01 pm

CUZ

Over the past 3 months, 4 analysts have published their opinion on Cousins Props (NYSE:CUZ) stock. The average 12-month price target for Cousins Props is $25.75, a decrease of 4.63% from the previous average price target of $27.00. The analysts' ratings range from somewhat bullish to somewhat bearish.

Portfolio Pulse from Benzinga Insights

September 12, 2023 | 3:01 pm

BAC

Analysts have provided various ratings for Bank of America (NYSE:BAC) within the last quarter, with 1 bullish, 5 somewhat bullish, and 3 indifferent. The average price target is $39.22, implying an upside from the current price of $28.585. This represents a 5.88% decrease from the previous average price target of $41.67.

Portfolio Pulse from Benzinga Insights

September 12, 2023 | 3:01 pm

TRXUSD

TRON's (CRYPTO: TRX) price has increased by 5.32% over the past 24 hours to $0.08. Over the past week, TRX has seen an increase of over 6.0%. The trading volume for the coin has climbed 72.0% over the past week, while the overall circulating supply of the coin has decreased by 2.66% to 89.23 billion. The current market cap ranking for TRX is #11 at $7.24 billion.

Portfolio Pulse from Benzinga Insights

September 12, 2023 | 3:01 pm

BGNE

Over the past 3 months, 7 analysts have published their opinion on BeiGene (NASDAQ:BGNE) stock. The majority of the ratings are bullish or somewhat bullish. The average 12-month price target for BeiGene is $270.71, a decrease of 14.78% from the previous average price target of $317.67.

Portfolio Pulse from Benzinga Insights

September 12, 2023 | 3:00 pm

BNBUSD

BNB's price has increased by 3.03% over the past 24 hours to $211.77, diverging from its trend over the past week where it experienced a 1.0% loss. The trading volume for the coin has risen 91.0% over the past week while the circulating supply has decreased 0.28% to 153.86 million, making up an estimated 76.93% of its max supply of 200.00 million. BNB's current market cap ranking is #4 at $32.61 billion.

Portfolio Pulse from Benzinga Insights

September 12, 2023 | 3:00 pm

ANET

Arista Networks (NYSE:ANET) has outperformed the market over the past 5 years by 14.65% on an annualized basis, producing an average annual return of 23.73%. If an investor had bought $1000 of ANET stock 5 years ago, it would be worth $2,831.93 today.

Portfolio Pulse from Benzinga Insights

September 12, 2023 | 3:00 pm

BDX

Becton Dickinson (NYSE:BDX) has outperformed the market over the past 20 years by 2.75% on an annualized basis, producing an average annual return of 10.33%. If an investor had bought $100 of BDX stock 20 years ago, it would be worth $726.06 today.

Portfolio Pulse from Benzinga Insights

September 12, 2023 | 3:00 pm

CTAS

Over the past 3 months, 7 analysts have published their opinion on Cintas (NASDAQ:CTAS) stock. The average 12-month price target for Cintas is $530.29, with a high of $580.00 and a low of $441.00. This average price target has increased by 5.94% over the past month.

Portfolio Pulse from Benzinga Insights

September 12, 2023 | 3:00 pm